Studentassistent 2

Celebrating prof. dr. Erik Frijlink – Innovation Day 2023

We are proud to announce that Prof. Dr. Erik Frijlink will receive the Innovation Day 2023 award from the Board of University of Groningen & Corina Prent (Director, RuG ventures)! As an academic innovator, Prof. Dr. Frijlink is the perfect example of a scientific entrepreneur. Throughout his career, he has: Developed breakthrough technologies which are a

Celebrating prof. dr. Erik Frijlink – Innovation Day 2023 Read More »

A leap of faith: from research to entrepreneurship

Our very own Corina Prent was interviewed by Hannah de Nobel from the University of Groningen about research and entrepreneurship. In an interesting article about Startup-City, VentureLab and SlimStampen, Corina tells you all about the bridge between the university and business. Read the entire interview below! Having ideas. Experimenting and trying. Wanting to change society.

A leap of faith: from research to entrepreneurship Read More »

EV Biotech secures €4.5m Seed Investment

Source: EV Biotech Fermentation is the future! EV Biotech offers a solution to the issue of pollution-heavy manufacturing methods by harnessing the power of fermentation combined with state-of-the-art computational methods. Microbial fermentation allows EV Biotech to work on a greener future while maintaining our current quality of life. It is incredible that something as small

EV Biotech secures €4.5m Seed Investment Read More »

Deep Atlas collaborates with Researchable

Deep Atlas collaborates with Researchable Deep Atlas, based in Groningen, is currently commercializing its revolutionary technology. Since 2017, the geological innovator has been working on a new method to image the mineralogy and eventually predict the permeability of rock samples from the deep subsurface using artificial intelligence. To better serve the market, Deep Atlas has

Deep Atlas collaborates with Researchable Read More »

MedTech company Implican raises €1M in seed round

From left to right: Peter Haasjes (NextGen), Ytsen van der Meer (NOM), Ivo Kooijman (CEO Implican), Klaas Havenga (chirurg/CMO Implican) en Roel Dekkers (NextGen) Medical device company, Implican, raised €1M in its first seed investment round. The funding, made by the Dutch investors NextGen Ventures, and the Investment and Development Agency for the Northern Netherlands

MedTech company Implican raises €1M in seed round Read More »